24 Ulcerative Colitis Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Ulcerative Colitis Studies in San Francisco

NCT00358943Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatme...

San Francisco, CA12,000 participantsGenzyme, a Sanofi Company

View Study Details

NCT06854198Recruiting

Glaucoma Screening to Enhance At-Risk Californians' Health

The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its ea...

San Francisco, CANA2,000 participantsUniversity of California, San Francisco

View Study Details

NCT05489705Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructi...

San Francisco, CA1,700 participantsBristol-Myers Squibb

View Study Details

NCT00904878Recruiting

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other...

San Francisco, CA1,500 participantsUniversity of California, San Francisco

View Study Details

NCT03487185Recruiting

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate ...

San Francisco, CANA1,500 participantsThe George Washington University Biostatistics Center

View Study Details

NCT04967989Recruiting

Clarifying the Optimal Application of SLT Therapy Trial

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or d...

San Francisco, CAPHASE3790 participantsUniversity of Pittsburgh

View Study Details

NCT07084142Recruiting

Developing a Digital Aid to Improve ICD Decisions

Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged hear...

San Francisco, CANA600 participantsStanford University

View Study Details

NCT06089083Recruiting

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients wit...

San Francisco, CA500 participantsUniversity of California, San Francisco

View Study Details

NCT05572632Recruiting

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the cou...

San Francisco, CANA387 participantsUniversity of California, San Francisco

View Study Details

NCT07573150Recruiting

Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy

This study will evaluate whether quantitative pupillometry measurements can be used to identify children at risk for postoperative opioid-induced respiratory depression (OIRD) following tonsillectomy....

San Francisco, CA300 participantsNeurOptics Inc

View Study Details

NCT07498426Recruiting

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO...

San Francisco, CAPHASE3300 participantsNovartis Pharmaceuticals

View Study Details

NCT05619900Recruiting

Registry of Patients Diagnosed With Lysosomal Storage Diseases

This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies,...

San Francisco, CA250 participantsUniversity of California, San Francisco

View Study Details

NCT05442567Recruiting

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this...

San Francisco, CAPHASE3240 participantsTakeda

View Study Details

NCT05924477Recruiting

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage devic...

San Francisco, CANA226 participantsUniversity of Pennsylvania

View Study Details

NCT06029972Recruiting

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will comp...

San Francisco, CAPHASE2176 participantsGilead Sciences

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

San Francisco, CAPHASE2165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT04844606Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...

San Francisco, CAPHASE3150 participantsEli Lilly and Company

View Study Details

NCT07071519Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab...

San Francisco, CAPHASE3120 participantsAbbVie

View Study Details

NCT07220525Recruiting

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode followin...

San Francisco, CANA100 participantsUniversity of California, San Francisco

View Study Details

NCT06600906Recruiting

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

This study evaluates an investigational scan called hyperpolarized carbon-13 pyruvate magnetic resonance imaging (MRI) in assessing treatment response in patients with pancreatic ductal carcinoma (PDA...

San Francisco, CA70 participantsUniversity of California, San Francisco

View Study Details

NCT07335510Recruiting

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerate...

San Francisco, CANA58 participantsColumbia University

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

San Francisco, CAPHASE345 participantsSpur Therapeutics

View Study Details

NCT05287126Recruiting

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in adolescents (≥ 12 years ...

San Francisco, CAPHASE236 participantsPfizer

View Study Details

NCT02431507Recruiting

Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety

The purpose of this study is to determine the safety and feasibility of the Magnap magnetic device in the treatment of obstructive sleep apnea (OSA)....

San Francisco, CANA10 participantsMichael Harrison

View Study Details

About Ulcerative Colitis Clinical Trials in San Francisco

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 24 ulcerative colitis clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 23,223 participants. Research is being sponsored by Genzyme, a Sanofi Company, University of California, San Francisco, Bristol-Myers Squibb and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in San Francisco — FAQ

Are there ulcerative colitis clinical trials in San Francisco?

Yes, there are 24 ulcerative colitis clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 24 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 18, 2026 from ClinicalTrials.gov